MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...
Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, according to a ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The ...